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Neuropathic pain is a widespread chronic pain state
that results from injury to the nervous system. Spinal
microglia play a causative role in the pathogenesis of
neuropathic pain through secretion of growth factors
and cytokines. Here, we investigated the contribu-
tion of TMEM16F, a protein that functions as a
Ca2+-dependent ion channel and a phospholipid
scramblase, to microglial activity during neuropathic
pain. We demonstrate that mice with a conditional
ablation of TMEM16F in microglia do not develop
mechanical hypersensitivity upon nerve injury. In
the absence of TMEM16F, microglia display deficits
in process motility and phagocytosis. Moreover,
loss of GABA immunoreactivity upon injury is spared
in TMEM16F conditional knockout mice. Collectively,
these data indicate that TMEM16F is an essential
component of the microglial response to injury and
suggest the importance of microglial phagocytosis
in the pathogenesis of neuropathic pain.INTRODUCTION
Neuropathic pain is a widespread and debilitating clinical condi-
tion that is triggered by a lesion in the nervous system. (Campbell
and Meyer, 2006; Costigan et al., 2009). It is becoming increas-
ingly apparent that spinal microglia play a causative role in the
pathogenesis of neuropathic pain (Scholz and Woolf, 2007). Pe-
ripheral nerve injury is associated with a pronounced recruitment
of microglia to the spinal cord, and a conversion of these cells
into a reactive state (Gehrmann et al., 1991), whereby they in-
crease synthesis and release of bioactive molecules (Clark
et al., 2007, 2013).
The most characterized mechanism through which microglia
contribute to neuropathic pain involves a molecular pathwayThis is an open access article undthat is dependent upon upregulation of microglial purinergic
P2X4 receptors (Beggs et al., 2012; Tsuda et al., 2003) and
increased release of brain-derived neurotrophic factor (BDNF)
from microglia, which acts on dorsal horn lamina I neurons to
shift their transmembrane anion gradient (Coull et al., 2003,
2005). As a result, inhibitory synaptic signaling through GABAA
and glycine receptors is diminished. Furthermore, loss of inhibi-
tion is exacerbated by reduced production and release of spinal
GABA (Lever et al., 2003; Moore et al., 2002) and injury-induced
loss of GABAergic interneurons in the dorsal horn (Scholz et al.,
2005; Sugimoto et al., 1990).
Microglia also have awell-established role in the detection and
removal of apoptotic neuronal material (Davalos et al., 2005; Fu
et al., 2014; Sierra et al., 2013). Upon injury, activated microglia
converge on the dorsal horn in response to chemokine and ATP
signaling and survey and modify sensory afferent input for dam-
age via probing and extension of their processes (Davalos et al.,
2005). Critical to this function is the activation of ion channels,
which, through modulation of membrane potential, cell volume,
and ion concentration promotes themovement of microglial pro-
cesses and the initiation of phagocytosis. However, it is not
known whether these mechanisms are important for aberrant
nociceptive processing under pathological pain conditions.
Recently, a family of ion channels has been identified
belonging to the TMEM16 family of proteins, which display func-
tional diversity and may contribute to microglial function. The
founding member of this family TMEM16A acts as a Ca2+-acti-
vated Cl channel (Caputo et al., 2008; Schroeder et al., 2008;
Yang et al., 2008), and another member TMEM16F has been pro-
posed to be a Ca2+-dependent phospholipid scramblase (Suzuki
et al., 2010), and a Ca2+-activated channel with either anion (Al-
mac¸a et al., 2009; Martins et al., 2011; Tian et al., 2012) or non-
selective cation (Yang et al., 2012) permeability. Each of these
molecular mechanisms could contribute to spinal microglial
function in neuropathic pain states.
To investigate whether TMEM16 channels play a role in neuro-
pathic pain, we assayed the expression levels of all TMEM16
family members in microglia and observed high enrichment ofCell Reports 15, 1–8, June 21, 2016 ª 2016 The Authors. 1
er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Figure 1. TMEM16 Expression and Generation of Conditional TMEM16F Knockout Mice
(A) RT-PCR analysis of TMEM16 transcripts in microglia, dorsal root ganglia (DRGs), kidney, and brain; p < 0.0001; n = 3.
(B) Representative images of injured sciatic nerve from indicated genotypes, 7 days after injury.
(C) Iba1 (green) and RFP (red) immunofluorescence in the lumbar spinal cord LysMCre/Rosa26tdRFP mouse, 3 days after injury.
(D) Iba1 (green) and RFP (red) immunofluorescence of microglia in the hippocampus from LysMCre/Rosa26tdRFP mouse.
(E) In situ hybridization for TMEM16F (red) and Iba1 (green) immunofluorescence of microglia in spinal cord, 7 days after injury.
(F) High-magnification representative images of TMEM16F in situ hybridization in control and cKO mice.
(G) In situ hybridization for TMEM16F in peritoneal macrophages cells from control and cKO mice.
Values are mean ± SEM. Scale bars, 100 and 40 mm (B), 100 mm (C), 20 mm (D, F, and G), 300 mm (E). See also Figure S1.
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mouse line in which TMEM16F is genetically ablated in cells
of the myeloid lineage. We demonstrate that, in the absence
of TMEM16F, microglia are dysmorphic and exhibit deficits
in process motility and phagocytosis. Moreover, TMEM16F con-
ditional knockout mice display a pronounced reduction in me-
chanical hypersensitivity after peripheral nerve injury, suggesting
that the classical scavenger function of microglia could be a fac-
tor in the pathogenesis of neuropathic pain.
RESULTS
TMEM16 Expression Profiling and Generation of a
TMEM16F Conditional Knockout Mouse Line
In order to identify TMEM16 proteins with a potential role in
pain processing, we performed expression profiling of all ten
TMEM16 familymembers in dorsal root ganglia (DRG),microglia,
and brain and compared their relative expression to basal levels
in kidney using qRT-PCR. We observed a strikingly high expres-
sion of TMEM16F in microglia that was not apparent in other tis-2 Cell Reports 15, 1–8, June 21, 2016sues tested (Figure 1A). Moreover, TMEM16F is the predominant
microglial TMEM16 transcript with levels 4-fold higher than the
next highest transcript TMEM16J.
To investigate the significance of the high expression of
TMEM16F in microglia, we generated conditional TMEM16F
knockout mice (Figure S1A). We tested two separate Cre driver
lines, CX3CR1Cre (Yona et al., 2013) and LysMCre (Clausen et al.,
1999), crossed with Cre-dependent reporter lines for selective
microglial and macrophage recombination. As previously re-
ported (Eriksson et al., 1993), we observed substantial micro-
gliosis in ipsilateral spinal cord upon injury. However, in
CX3CR1Cre::Rosa26tdRFP mice, reporter expression was evident
in both microglia and neurons throughout the spinal cord (Fig-
ureS1E). In contrast,LysMCre::Rosa26tdRFPmicedisplayedselec-
tive expression in macrophages recruited to the injury site, and in
microglia in the spinal cord and brain (Figures 1B–1D). In situ hy-
bridization for TMEM16F and immunostaining for microglial
marker Iba1 in spinal cord sections from injured mice, confirmed
robust TMEM16F expression in spinal microglia from LysMCre::
TMEM16Ffl/+ mice and a decrease in TMEM16F mRNA in
Figure 2. Microglial TMEM16F Is Required for the Development of Mechanical Hypersensitivity in the PNL Neuropathic Pain Model
(A) Paw withdrawal thresholds of TMEM16Ffl/fl (control) and LysMcre/TMEM16Ffl/fl (cKO)mice showing ipsilateral (ipsi) and contralateral (contra) paw withdrawals
before and after partial nerve ligation (PNL). n = 9; p < 0.05.
(B) From left to right: microglial Iba1 immunofluorescence in the lumbar spinal cord after injury (left side), magnified images from control and cKO tissues 2 days
after PNL. Bar graphs show microglial densities in injured (PNL) and non-injured (sham) tissue 2 (left) and 7 (right) days after injury. n = 8/9; p < 0.05.
(C) Neuronal marker NeuN immunofluorescence in the ipsilateral dorsal horn from control (top) and cKO (bottom) mice; bar graph showing neuronal density in the
imaged volume. n = 10/7; p < 0.05.
(D) CD68 (red) and Iba1 (green) immunofluorescence in the ipsilateral dorsal horn from control and cKOmice. CD68 immunoreactivity in Iba1 positive cells at 2 and
7 days after injury. n = 6; p < 0.01.
(E) Top: Iba1 (red) and DAPI (blue) immunolabeling in the ipsilateral dorsal horn; 3D image segmentation using IMARIS Bitplane surface (middle) and filament
(bottom) algorithms.
(F) Frequency distribution of microglial volume in the ipsilateral dorsal horn from control and cKO mice, n = 79/277 cells; p = 0.005.
(G) Frequency distribution of microglial total branch length in the ipsilateral dorsal horn from control and cKO mice; p = 0.0293.
Values are mean ± SEM. Scale bars represent 100 mm (B), 30 mm (C), 20 mm (D), 40 mm, and 7 mm (E). See also Figures S2 and S3.
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(Figures 1E–1G). We thus performed all further analysis on
the LysMCre:: TMEM16Ffl/fl (cKO) line using TMEM16Ffl/fl (in the
absence of Cre) or LysMCre:: TMEM16Ffll+ mice as controls.
Microglial TMEM16F Is Required for Neuropathic Pain
Development
To determine whether TMEM16F contributes to microglial
function in pain states, we monitored nociceptive behavior in
LysMCre::TMEM16Ffl/flmice in models of neuropathic and inflam-
matory pain. In control mice subjected to partial nerve ligation
(PNL), we observed a pronounced mechanical allodynia that
peaked at 7 days post-injury. Strikingly, deletion of TMEM16F in
microglia andmacrophagesprevented thedevelopmentof allody-
nia, and mechanical withdrawal thresholds remained at pre-injury
levels throughout the monitoring period (Figure 2A), an effect that
was observed in both male and female mice (Figure S2A).
To investigate thecontributionofmicroglial TMEM16F to inflam-
matory pain, we used the Complete Freund’s Adjuvant (CFA)
model. We observed mechanical allodynia 48 hr after intraplantar
injection of CFA in control animals. In contrast to the PNL model,
LysMCre::TMEM16Ffl/flmicedevelopedmechanical hypersensitiv-
ity to the same extent as litter mate controls (Figure S2B).
To explore whether TMEM16F contributes to proliferative,
migratory, and phagocytic responses of microglia upon periph-
eral nerve injury, we performed quantitative image analysis onimmunohistologically labeled spinal cord sections. Intriguingly,
the total number of Iba1 positive microglia increased more
rapidly after injury in lumbar spinal cords from LysMCre::
TMEM16Ffl/fl compared to control mice, and 3 days post-injury
this had already reached maximal levels. In contrast, microglial
density from control mice required 7 days to reach similar levels
(Figure 2B).We observed no difference in the number of neuronal
cell bodies in at seven days post-injury between control and con-
ditional knockout (cKO) animals (Figure 2C).
We investigated the activation status of microglia by quanti-
fying lysosomal protein CD68 immunoreactivity (Holness and
Simmons, 1993) in Iba1 positive cells and observed a dramatic
increase at 2 days post-injury in control spinal cords that had
normalized to baseline levels 7 days post-injury. In contrast, in
spinal cords from LysMCre::TMEM16Ffl/flmice, CD68 immunore-
activity was significantly reduced compared to control (Fig-
ure 2D), suggesting that microglial phagocytic activity was
impaired in the absence of TMEM16F.
We further examined morphological characteristics of spinal
microglia, using 3D reconstruction of spinal cord confocal stacks
and segmentation of Iba1 positive cells (Figure 2E). Microglia
were significantly smaller in size and less branched in the ipsilat-
eral dorsal horn of cKO mice compared to controls (Figures 2F
and 2G).
As an additional measure of microglial function, we performed
immunostaining for P2X4 receptors. Upon PNL, there was anCell Reports 15, 1–8, June 21, 2016 3
Figure 3. Histological and Biochemical Analysis of Macrophages
Recruited at the Nerve Injury
(A) Iba1 (red), CD68 (green), and DAPI (blue) immunofluorescence in the ipsi-
lateral nerve cryosections from control and cKOmice, 7 days after injury. Scale
bar, 20 mm.
(B) Density of Iba1 positive macrophages at the distal side of the nerve injury at
3 and 7 days after injury. n = 3, p < 0.05.
(C) Size of Iba1 positive macrophages on the distal side of the nerve injury at 3
and 7 days after injury; n = 3; p < 0.05.
(D) CD68 intensity in Iba1 positive macrophages, 7 days after PNL; n = 3;
p > 0.05.
(E) Cytokine/chemokine array blots incubated with contralateral and ipsi-
lateral sciatic nerve extracts (130 mg) from control and cKO mice, 4 days after
injury.
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(92% ± 17%; Figure S3).
To determinewhether genetic ablation of TMEM16F perturbed
the function of macrophages in the PNL model, we assessed
macrophage recruitment, morphology, and activation at the
nerve injury site (Figure 3A). In contrast to data from microglia,
we observed no significant difference in the number (Figure 3B),
size (Figure 3C), or CD68 immunoreactivity (Figure 3D) of macro-
phages in cKO mice compared to controls. Moreover, release of
pro-inflammatory cytokines and chemokines upon nerve injury
was also not significantly changed in LysMCre::TMEM16Ffl/fl
mice (Figures 3E–3G). Thus, TMEM16F may play a more promi-
nent role in microglia compared to peripheral macrophages in
the PNL model of neuropathic pain.
TMEM16F Influences Microglia Motility and Engulfment
of Neuronal Material
We developed an ex vivo preparation for live imaging of
microglia, using a triple transgenic CX3CR1GFP:: LysMCre::
TMEM16Ffl/fl, in which GFP is robustly expressed in microglia.
We examined microglial branch extension in hippocampal sli-
ces by applying an ATP puff through a glass micropipette to
mimic ATP release from damaged neurons (Davalos et al.,
2005). Strikingly, the directed movement of microglia branches
was significantly reduced in hippocampal slices from cKOGFP
compared to ControlGFP mice (Figure 4A; Movie S1). Using
tracking analysis of single microglial branches, we observed
that the mean elongation velocity of single tracks after an ATP
puff was significantly reduced in cKOGFP (1.11 ± 0.03 mm/min)
compared to ControlGFP mice (1.28 ± 0.06 mm/min; p = 0.017, t
test).
As an additional marker of peripheral sensory input into the
spinal cord, Cholera Toxin B (CTB)-Alexa 647 was injected intra-
neurally into the sciatic nerve when performing PNL surgery.
During live imaging from spinal cord slices, microglia from
cKOGFP mice displayed significantly reduced motility (Figure 4B;
Movie S2). Strikingly, we observed that the engulfment of CTB-
Alexa-647-labeled nerve terminals was reduced in cKOGFP
compared to ControlGFP mice (Figure 4C; Movie S3).
In agreement with observations from ex vivo spinal cord
preparations, isolated microglia from Rosa26Clsensor::LysMCre::
TMEM16Ffl/fl (cKOClsensor) mice displayed reduced phagocy-
tosis of fluorescently labeled yeast, compared to control
Rosa26Clsensor:: LysMCre::TMEM16Ffl/+ (1.6 ± 0.2, n = 96 for
control versus 0.9 ± 0.1, n = 87 for cKO, p < 0.05, t test, at
30 min) (Movie S4).
What is the link between impairedmicroglial phagocytosis and
reduced neuropathic pain in TMEM16F cKO mice? Intriguingly,
sciatic nerve injury has previously been associated with a(F) Pixel densities of selected cytokine spots in the contralateral and ipsilateral
sciatic nerve lysates from control mice. p < 0.05, p < 0.01. n = 3 sets of pooled
samples from four mice each.
(G) Pixel densities of selected cytokine spots in the ipsilateral sciatic nerve
lysates from control and cKO mice 4 days after injury, p > 0.05.
Values are mean ± SEM.
Figure 4. TMEM16F Regulates Microglia Branch Motility and Engulfment of Neuronal Material
(A) Top: fluorescence changes in a ControlGFP hippocampal slice near the tip (green squares). Bottom: relative fluorescence increasemeasured in a 10-mm radius
from the ATP-containing (3 mM) pipette in acute hippocampal slices from mice of indicated genotypes, n = 9/24 fields in three of seven mice; p < 0.05 from 25 to
34 min.
(B) Top: ipsilateral dorsal horn sections from mice of indicated genotypes. The selected segmented GFP positive microglia (yellow) is surrounded by a bounding
box (red), whichwas used for branchmotility analysis. Bottom: SD of the bounding box from itsmean value over time to quantify microglia branchmotility in spinal
cord slices, from mice of indicated genotypes.; n = 44/45 cells; p < 0.0001.
(C) Segmentation of GFP positive microglia (green) and Alexa-647-labeled neurons, external to microglia (blue) and internalized (pink). Ratio of internalized over
total labeled neuronal material to quantify engulfed neuronal terminals by microglia over time.
(D) Top: image segmentation: GABA positive neuron (red) colocalizes (white) within Iba1 positive microglia (green) after injury. Bottom: Iba1 (green) and GABA
(red) immunofluorescence in the ipsilateral and contralateral dorsal horns from control and cKOmice, 3 days after injury, with zoomed images from lamina I–III in
the insets.
(E) Density of GABA-positive neurons in the lamina I–III of the dorsal horn of control and cKO mice, 3 days after injury. p < 0.05, n = 5.
Values are mean ± SEM. Scale bar, 50 mm (B and C) and 60 mm (D). See Movies S1, S2, S3, and S4.
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turn, reduces inhibitory control in the spinal cord and promotes
mechanical hypersensitivity (Scholz et al., 2005; Sugimoto
et al., 1990). We therefore asked whether loss of GABA might
be spared in TMEM16F cKO mice, perhaps as a consequence
of the diminished phagocytic capacity of microglia. Utilizing
immunohistochemistry for GABA in lumbar spinal cord sections,
we observed a significant reduction in GABA staining in the
ipsilateral dorsal horn of control mice upon injury (Figure 4D).
Strikingly, in TMEM16F knockout mice this reduction was not
apparent, and ipsilateral and contralateral sides displayed
similar numbers of GABA positive neuron (Figure 4E).DISCUSSION
In this study, we explored the significance of high expression
levels of TMEM16F in microglia via conditional ablation of the
TMEM16F gene in cells of the myeloid lineage. We demonstrate
that TMEM16F conditional knockout mice do not develop me-
chanical hypersensitivity after peripheral nerve injury and that
this is associated with a reduced phagocytosis by spinal micro-
glia. Moreover, in both in vivo and ex vivo preparations, microglia
exhibit deficits in function that is reflected in their altered
morphology, expression of activation markers, and diminished
branch motility and phagocytic capacity. Together our dataCell Reports 15, 1–8, June 21, 2016 5
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tant component in the cascade of events that lead to altered
nociceptive processing in neuropathic pain.
We opted for a conditional genetic strategy to delete
TMEM16F and after assessing two Cre driver lines (Clausen
et al., 1999; Yona et al., 2013) for reporter gene expression,
selected LysMCre as this drove expression specifically in micro-
glia in the spinal cord. However, Cre-mediated recombination
was not evident in all microglia. We addressed this issue in
in vitro studies by using triple transgenic mice expressing Cre-
dependent reporter and only selecting fluorescent cells for anal-
ysis. In in vivo and ex vivo studies, however, the incomplete dele-
tion of TMEM16F from all microglia will presumably lead to an
underestimation of phenotypes. A further complication arising
from use of the LysMCre driver lines is that recombination will
also occur in macrophages. We observed no differences in
macrophage number, morphology, or activation at the injury
site in the sciatic nerve in cKO versus control mice, or in the
expression of inflammatory mediators in the injured nerve. More-
over, in the CFA inflammatory pain model, which does not pro-
voke microglial activation (Li et al., 2013; Lin et al., 2007), noci-
ceptive thresholds were similar between genotypes. These
data imply that TMEM16F has amore prominent role in microglia
than macrophages in neuropathic pain models. The further
development of Cre-driver lines, which selectively target micro-
glia with high efficiency, for example, inducibleCx3cr1CreERmice
(Parkhurst et al., 2013), will allow for a more direct assessment of
these issues.
Upon peripheral nerve injury, microglia migrate to the spinal
cord, proliferate, and assume an activated state (Gehrmann
et al., 1991; Guan et al., 2016). This is accompanied by an in-
crease in P2X4 receptor expression, release of BDNF, and disin-
hibition of lamina I neurons (Coull et al., 2003, 2005). We there-
fore asked whether deletion of TMEM16F in microglia would
impact upon any of these mechanisms. We observed no
decrease in microglial recruitment to the spinal cord (indeed
this was significantly increased in TMEM16F cKOmice), and up-
regulation of P2X4 receptor immunoreactivity in the ipsilateral
dorsal horn of TMEM16F cKO mice at levels similar to that
seen in control mice.
Other factors have also been demonstrated to contribute to a
loss of inhibition in the spinal cord, including a decrease in GABA
production and release, and degeneration of GABAergic inter-
neurons (Bra´z et al., 2012; Moore et al., 2002; Scholz et al.,
2005; Sugimoto et al., 1990). Intriguingly, we observed a reduc-
tion inGABA immunoreactivity in lamina I–III of the ipsilateral dor-
sal horn of control mice, which was absent in the cKO mice.
Together with our data on the impaired phagocytic capacity of
TMEM16F cKO microglia, we speculate that diminished phago-
cytosis may spare GABA loss and thus reduce disinhibition and
the development of mechanical hypersensitivity. This mecha-
nism could occur independently of complete loss of inhibitory
neurons by necrosis or apoptosis and instead happen via selec-
tive pruning of GABAergic terminals. Indeed, recent work by Pe-
titjean et al. (2015) has demonstrated that parvalbumin-positive
interneurons do not die after peripheral nerve injury but exhibit
reduced connectivity with PKCg neurons in the dorsal horn.
Thus, in addition to the well-established role of microglia in6 Cell Reports 15, 1–8, June 21, 2016releasing bioactive factors (Clark et al., 2007, 2013), their clas-
sical phagocytosis functionmay also contribute to the pathogen-
esis of neuropathic pain. Further investigation of the integrity of
spinal pain circuitry in TMEM16F cKO mice, as well as its role
in other cell types (Jiang et al., 2016; Sorge et al., 2015), will
shed more light on this issue.
TMEM16F functions as both a calcium dependent ion channel
and a phospholipid scramblase. Therefore, an important ques-
tion that arises from our data is whether deficits in microglial
phagocytosis are caused by alterations in ion transport or in
phosphatidylserine exposure in cKO cells. Intriguingly, both pro-
cesses have previously been shown to be important for phago-
cytosis and ramification in macrophages and microglia suggest-
ing that TMEM16F could utilize multiple mechanisms to
modulate microglial function (Callahan et al., 2000; Eder et al.,
1998). Recently, TMEM16F was also demonstrated to act down-
stream of P2X7 receptors and influence immune defense by
macrophages (Ousingsawat et al., 2015). While we observed
no deficits in macrophage function upon nerve injury in
TMEM16F knockout mice, other purinergic receptors such as
P2Y12 receptors have been implicated in microglial phagocy-
tosis. Indeed, P2Y12 is expressed exclusively by microglia
(Hickman et al., 2013; Kobayashi et al., 2011) and has been
demonstrated to play a key role in ATP-mediated branch rear-
rangement and phagocytosis of injured axons (Haynes et al.,
2006; Maeda et al., 2010; Ohsawa et al., 2010). Investigation of
interactions between TMEM16F and P2Y12 could therefore be
a useful starting point for developing therapeutic strategies
that target microglia in neuropathic pain states.
EXPERIMENTAL PROCEDURES
Details are further described in Supplemental Experimental Procedures.
Animals
Mice were bred and maintained at the EMBL Mouse Biology Unit, Montero-
tondo, in accordance with Italian legislation under license from the Italian Min-
istry of Health. The TMEM16F targeting strategy was designed to allow Cre-
mediated excision of the exons 13 of the TMEM16F, resulting in a frameshift
mutation in exon 14. The LysMCre line (Clausen et al., 1999) was used as a
driver line for conditional ablation of TMEM16F. CrosseswithRosa26tdRFP,Ro-
sa26Clsensor, and CX3CR1GFP mouse lines yielded reporters for visual and
functional tracking.
Pain Models and Behavioral Assays
Partial nerve ligation of the left sciatic nerve was performed on mice of both
sexes to induce neuropathic pain behavior as described previously (Seltzer
et al., 1990). Mice were tested blindly for mechanical allodynia using calibrated
von Frey filaments of increasing force applied to the hindpaw and fitting the
paw withdrawal probability. Inflammatory pain was induced by intraplantar in-
jection of Complete Freund’s Adjuvant (CFA). To trace central sensory end-
ings, 2-ml injections of 0.5% cholera Toxin-B (CTB) Alexa Fluor 647 conjugate
were performed into the sciatic nerve.
Double RNA Fluorescent In Situ Hybridization and
Immunofluorescence
In situ hybridization (ISH) was performed on spinal cord cryosections using a
fluorescein-labeled probe generated from a full-length TMEM16F cDNA.
Briefly, sections were fixed in 4% paraformaldehyde (PFA), digested with pro-
teinase K for 5 min, acetylated, and hybridized with the probes in 50% form-
amide, 5 3 saline sodium citrate (SSC), 5 3 Denhardt’s solution, 500 mg/ml
salmon sperm DNA, and 250 mg/ml tRNA overnight at 56C. After stringent
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dx.doi.org/10.1016/j.celrep.2016.05.039post-hybridization washes, sections were blocked and incubated with mouse
anti-fluorescein (Roche; at 1:100) and rabbit anti-Iba1 (Wako; at 1:200), fol-
lowed by anti-mouse Alexa 555 and anti-rabbit Alexa 488.
Real-Time PCR
Homogenates of DRG, brain, kidney, L4–L6 segment of the lumbar spinal cord,
and lysates ofmicroglia cells were subjected to total RNA extraction and qPCR
according to standard protocol. Each mRNA expression level was normalized
to ubiquitin or GADPH.
Western Blotting
Harvested tissues were homogenized on ice in lysis buffer proteinase inhibitor.
10-mg lysates were loaded for gel electrophoresis. Western blot was per-
formed using standard techniques with rabbit anti-TMEM16F (HPA038958,
Sigma).
Immunohistochemistry
Immunohistochemistry was performed on paraformaldehyde-fixed cryosec-
tions and free floating sections according to standard protocols. The following
primary antibodies were incubated overnight at 4C: rabbit anti-Iba1 (019-
19741, Wako; 2.5 mg/ml), rat anti-CD68 (Abd Biotech; 10 mg/ml), mouse anti-
NeuN (1:250), rabbit anti-P2X4 receptor (ab82329, Abcam; 1:200), rabbit
anti-RFP (600-401-379, Rockland; 5 mg/ml), and rabbit anti-GABA (A2052,
Sigma;1:2,000). For co-staining with RFP or P2X4R or GABA, a mouse goat
anti-Iba1 (Novus; 5 mg/ml) was used. Anti-rabbit-, anti-rat, and anti-mouse
Alexa 488, 546, or 647 secondary antibodies (2 mg/ml) (Life Technologies)
were used. Z optical series covered 42 mm of thickness for free floating sec-
tions and 12 mm for cryosections with 0.5 mm step.
Time-Lapse Microscopy of Microglia
Time-lapse imaging of microglia in the culture and spinal cord slices was car-
ried out on a spinning-disk confocal ultraview Vox (Cellular imaging, Perki-
nElmer) at 37C and 5% CO2. For spinal cord, ex vivo time-lapse Z optical se-
ries covered 40 mm of thickness with 0.5 mm step. For phagocytosis assays,
primary microglia cells expressing endogenous ClSensor (Batti et al., 2013)
were co-incubated with fluorescent heat-killed S. cerevisiae yeast. Images
were taken every minute for 30 min.
Time-lapse imaging of microglial branch extension in hippocampal slice
fromCX3CR1GFPmice was performed at room temperature during 2–7 hr after
cutting. Adenosine 50-triphosphate magnesium salt (ATP, 2 mM; Sigma-Al-
drich) was pressure applied (100 ms; 5 psi) from the glass pipette placed in
the stratum radiatum. GFP fluorescence was measured every 10 s for
50 min in a 20-mm diameter area around the pipette tip to quantify the speed
of GFP-expressing microglial processes extension.
Image Analysis
Three-dimensional reconstructions of confocal stacks and surface rendering
were performed with Imaris Bitplane Software (Bitplane). Surface, Filament,
and Spots Imaris modules were used for segmentation and tracking of micro-
glial cells, microglia processes, and neuron terminals, respectively. Tracking
analysis of single microglial processes in the hippocampal slice was per-
formed using ImageJ software.
Cytokine Arrays
Protein extracts from sciatic nerve fragments were processed with pre-
spotted cytokine/chemokine array according to manufacturer’s instructions
(R&D Systems, mouse cytokine array panel A, no. ARY006). Signal intensity
was analyzed in ImageJ, background subtracted, and averaged on duplicates
and between three sets of four mice.
Statistical Analysis
Statistical significance was determined as p < 0.05 by one-way ANOVA (Fig-
ures 2A, 3D, 3F, 3G, and 4C) or two-way ANOVA test (Figures 1A, 2B–2D,
3B, 3C, and 4B) followed by Bonferroni post hoc test, Student’s t test (Fig-
ure 4A), c2 test, or Mann Whitney test (Figures 2F and 2G).SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Results, Supplemental
Experimental Procedures, three figures, and four movies and can be found
with this article online at http://dx.doi.org/10.1016/j.celrep.2016.05.039.
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Supplemental Results, related to Fig.1 
We designed a targeting construct whereby exon 13 of the TMEM16F gene 
was flanked by loxp sites, allowing for excision of the exon by Cre-mediated 
recombination, and a subsequent frame-shift mutation in exon 14 (mimicking 
a human mutation observed in Scott syndrome patients (Suzuki et al., 2010). 
A frt flanked neomycin cassette was introduced to enable selection of 
correctly targeted ES cells. Positive ES cell clones were identified using 
southern hybridization, and chimeric mice were obtained that were crossed 
with Flp-expressing transgenic mice to remove the neomycin cassette.  
We first generated ubiquitous TMEM16F knockout mice (TMEM16F-/-) by 
crossing mice with the DeleterCre line (Schwenk et al., 1995). Further crosses 
were undertaken to remove the Cre transgene and validation of TMEM16F 
ablation was achieved using southern hybridization of genomic DNA and 
western blotting from membrane fraction of spleen homogenates (Fig. 
S1B,C). From crosses of TMEM16F+/- mice we observed a reduction in the 
number of TMEM16F-/- offspring compared to expected Mendelian ratios 
(Fig.S1D). Moreover, TMEM16F-/- mice had reduced body weight in 
  
comparison to their +/+ or +/- littermates (median value: -10% weight 
difference, n=6; p> 0.005). We thus opted for a conditional approach to target 
TMEM16F in microglia.  
  
  
 
 
  
Figure S1, related to Fig. 1 
A) Schematic representation of the genomic locus of the TMEM16F gene (top), of the 
targeted allele (middle) and floxed and flipped alleles (bottom).  Neo and Kan: 
Neomycin and Kanamycin resistance gene; loxP and FRT sites are indicated by grey 
arrowheads; restriction enzymes sites are indicated by blue arrowheads for HindIII 
and red arrowheads for Kpn1. B) Southern blot analysis of genomic DNA for 
indicated genotypes TC: targeted cells; fl/fl: floxed mice C) Representative western 
immunoblot of TMEM16F in three different tissues from indicated genotypes. Control: 
HEK293 cells transfected with TMEM16F DNA; liv: Liver homogenates; spl: spleen 
homogenates; br: brain homogenates; D) TMEM16F deletion influences the 
expected Mendelian ratios litters from TMEM16F+/- crosses (n=12 litters, p<0.05 χ2 
test) E) Representative Z-stack projection of the ipsilateral (top) and contralateral 
(bottom) dorsal horn of the spinal cord from a CX3CR1cre::Rosa26tdRFP mouse 5 days 
after PNL. Anti-RFP (red) , in green anti-NeuN(green) staining. Scale bar: 50 μm. 
  
  
 
Figure S2, related to Fig. 2 
(A) Graph showing the evoked responses to von Frey filaments of the ipsilateral (ipsi) 
and contralateral (contra) paw in female (F) and male (M) mice seven days after 
PNL. Data are expressed as paw withdrawal threshold value and are presented as 
mean ± SEM. N=4/5 for males and 4/3 for females; p<0.05 between genotypes, 
using One-Way ANOVA. 
(B) Graph showing the evoked responses to von Frey filaments of the ipsilateral (ipsi) 
and contralateral (contra) paw two days after Complete Freunds Adjuvant (CFA) 
injection. Data are expressed as paw withdrawal threshold value and are presented 
as mean ± SEM. N=6/8; p>0.05 between genotypes, using One-Way ANOVA.  
 
 
 
  
  
 
Figure S3, related to Fig. 2 
Representative images of lumbar spinal cord slice from TMEM16Ffl/fl (control) and 
LysMcre::TMEM16Ffl/fl (cKO) mice stained with anti-Iba1 (green, top) and anti-P2X4 
receptor (red, bottom) antibodies. P2X4 immunoreactivity is increased on the right 
side of the slice, ipsilateral to PNL, marked by numerous Iba1+ microglia. Scale bar 
100 µm. Mean grey levels of P2X4 channel were measured across dorsal horn area 
(lamina I-III) and normalized to the contralateral side.  
 
  
  
 
Movie S1, related to Fig. 4A 
Representative time lapse movies showing fluorescent microglia branch motility 
towards an ATP pipette puff. On the left: CX3CR1GFP:: TMEM16ffl/fl (ControlGFP).On 
the right: CX3CR1GFP::LysMCre::TMEM16ffl/fl (cKOGFP) mice. 
T= 0 corresponds to start of acquisition; t=4 min corresponds to Mg-ATP application, 
5 psi, 100 ms. Green squares indicate the point of the pipette tip. 
 
Movie S2, related to Fig. 4E 
Representative Z-stack time lapse movie showing segmented spinal microglia (green 
and yellow) from a ControlGFPmouse followed by a cKOGFP mouse, and analysis of 
processes motility using a microglia tracking algorithm over time. One frame every 
minute for a total of 30 minutes. Scale bar 50 μm. 
 
Movie S3 related to Fig. 4G 
3D View of segmented GFP positive microglia (green) and segmented CTB-
Alexa647 labelled neuronal terminals (cyan) in the dorsal horn of an ipsilateral spinal 
cord slice 3 days after surgery.  Segmented neuronal terminals co-localized with 
GFP signal are considered internalized (purple). 
 
 
Movie S4, related to Fig.4 
Representative movie of microglia (blue) from LysMCre::TMEM16Ffl/+::Rosa26Cl-Sensor 
(ControlCl-sensor) (left) and LysMCre::TMEM16Ffl/fl::Rosa26Cl-Sensor (cKOCl-Sensor) (right) 
mice, incubated with fluorescent yeast (orange) for a phagocytosis assay. One frame 
every minute for a total of 30 minutes.  
 
  
  
Supplemental experimental procedures 
 
Generation of the TMEM16F conditional knockout allele and genotyping 
The TMEM16F targeting strategy was designed to allow Cre-mediated excision of 
the exons 13 of the TMEM16F, resulting in a frame-shift mutation in exon 14. The 
TMEM16F gene-targeting vector contained a loxP site located 5’ of exon 13, a 
neomycin resistance (neor) gene flanked with two frt sites, and a loxP site located 3’ 
of exon 13. 
The targeting construct was transfected into A9 clone ES cells. Southern blotting of 
individual ES cell clones was used to identify homologous recombinants. DNA was 
digested with Kpn1 or HindIII and hybridized with a 3` or 5` probe, respectively. 
Using the 5` probe, three DNA fragments were obtained: a 11600 bp (wild-type) 
fragment, a 7200 bp (targeted cells and floxed) fragments and 10900 bp (knock out) 
fragment. Using the 3` probe, two DNA fragments were obtained corresponding to a 
9300 bp (wild-type) fragment, 7600 bp (targeted cells and floxed and knock-out) 
fragments. Positive clones were injected into 8-cell stage embryos to generate mice 
heterozygous for the targeted allele. Mice were first crossed with FLP-expressing 
transgenic mice to remove the frt flanked neoR cassette and then to LysMCre or 
DeleterCre mice. These genetic manipulations resulted in the generation of TMEM16F 
flipped and floxed alleles, TMEM16F conditional knockout alleles and TMEM16F null 
alleles, respectively. All analysis was performed on mice that did not carry the FLP or 
DelCre alleles. 
Mouse genotype was verified by PCR using primers 
AAACAGTCACACTGGTGGGTGCC (forward for wild-type and LoxP (fl) allele), 
AGAGCAACTCCGCCAACCCCTTAG(reverse forward for wild-type and LoxP (fl) 
allele) and TAGACATTCTTTAGTGACAC (forward for null allele) and 
TGCTATGTTATCAAATACTAGC (reverse for null allele). The presence of the FLP 
transgene was determined with the following primers; 
  
CCCATTCCATGCGGGGTATCG and GCATCTGGGAGATC ACTGAG. The 
presence of Cre recombinase was checked with primers 
GCACTGATTTCGACCAGGTT and GAGTCATCCTTAGCGCCGTA.All primers were 
purchased from Sigma Aldrich, Italy. 
 
Animals 
Mice were bred and maintained at the EMBL Mouse Biology Unit, Monterotondo, in 
accordance with Italian legislation under license from the Italian Ministry of Health. 
TMEM16F conditional KO mice were crossed with the following mouse line: 
CX3CR1Cre(Yona et al., 2013),LysMCre (Clausen et al., 1999),  Rosa26tdRFP(Luche et 
al., 2007), Cl-sensor (Batti et al., 2013), CX3CR1GFP (Jung et al., 2000), Avil-
Cre::Rosa26SNAPCaaX (Yang et al., 2008). 
LysMCre::TMEM16Ffl/fl were referred to as cKO, TMEM16Ffl/fl (in the absence of Cre) 
or LysMCre::TMEM16Ffl/+ mice were referred to as controls, CX3CR1GFP:: 
LysMCre::TMEM16Ffl/- and CX3CR1GFP::LysMCre::TMEM16Ffl/fl were referred to as 
cKOGFP, CX3CR1GFP::LysMCre::TMEM16Ffl/+ or CX3CR1GFP::TMEM16FFl/+ (in the 
absence of Cre) mice were referred to as ControlGFP, Cre::TMEM16Ffl/-::Rosa26Cl-
sensor
 and Cre::TMEM16Ffl/fl::Rosa26Cl-sensor mice were referred to as cKOCl-sensor, 
LysMCre::TMEM16Ffl/+::Rosa26Cl-Sensor and LysMCre::TMEM16F+/+::Rosa26Cl-sensor mice 
were referred to as ControlCl-Sensor. 
 
Pain models and intraneural Injection 
Mice of both sexes were subjected to partial nerve ligation of the left sciatic nerve 
(Seltzer et al., 1990) under isoflurane anaesthesia (Esteve).  Briefly, after exposure 
of the left sciatic nerve at high-thigh level a 7-0 silicon- treated silk suture (Ethicon, 
Italy) was inserted into the nerve and tightly ligated so that the dorsal 1/3-1/2 of the 
nerve thickness was trapped in the ligature. In sham operated mice the nerve was 
left intact and the wound was closed. In all animals, the right leg and sciatic nerve 
  
were untouched; animals were tested three and seven days after surgery. Cholera 
Toxin-B (CTB) (lifetechnologies) injection was performed right after nerve ligation. 
The nerve was subjected to serial injection of CTB Alexa Fluor 647 conjugate 
(0.5%in 2 μl of saline solution). 
Intraplantar injection of Complete Freunds Adjuvant (CFA) (Sigma Aldrich, Italy) was 
used to model inflammatory pain. 20 μl CFA (Heat-killed Mycobacterium 
butyricum,10 mg/ml in mineral oil) was injected into the left hind paw under brief 
isoflurane anaesthesia. The inflammation was confined to the left paw throughout the 
observation period. Sham animals were injected with 20 μl of mineral oil.  
 
Behavioral analysis 
All mice were habituated to the testing environment for three days. All mice were 
tested for mechanical hypersensitivity of the hindpaw one day before and three and 
seven days after surgery. For the inflammatory model animals were tested 48 hours 
after injection. Mechanical allodynia was measured using the von Frey test. Briefly, 
von Frey filaments ranging from 0.04 g to 1.2 g of force were applied perpendicularly 
to the plantar surface of the paw through wire-mesh observation cages. The paw 
withdrawal threshold (PWT) was determined by sequentially increasing the stimulus 
strength and fitting percentage withdrawal with sigmoidal function.  
 
Cell culture preparation  
Microglial cell cultures were obtained from mixed glia cultures derived from the 
cerebral cortices of newborn mice (P0-P2). Cortices were digested in 20 U/ml papain 
(Sigma Aldrich, Italy)for 20 min at 37 °C followed a gentle trituration. The dissociated 
cells were washed, suspended in DMEM (Lifetchnologies, Italy) supplemented with 
10% fetal bovine serum (FBS, Lifetchnologies, Italy), 100 U/ml penicillin and 
0.1 mg/ml streptomycin (Lifetchnologies, Italy), and plated (5 × 105cells/cm2) on 
flasks coated with poly-L-lysine (100 μg/ml) (Sigma Aldrich, Italy). After 7–9 days, 
  
cells were shaken for 2 h at 37 °C to detach and collect microglial cells. These 
procedures gave almost pure microglial cell populations as previously described 
(Lauro et al., 2010). Once collected, microglial cells (105) were plated on round glass 
coverslips (12 mm diameter) or on glass bottom dishes (MatTek Corporation, USA) 
coated with poly-L-lysine (100 μg/ml) and used for experiments after 2-4 days. 
 
Tissue slice preparation 
Spinal cord slice were taken from 8-13 weeks old mice. After cervical dislocation a 
laminectomy was performed to expose the lumbar spinal cord. The L3-L5 segment of 
spinal cord was freed, embedded on 2% low melting agarose (Promega, USA) in 
water and incubated in cold HEPES buffer solution of the following composition (in 
mM): NaCl 140; 193  NaOH 4.55; HEPES 10; KCl 4; Glucose 5; MgCl2 1; CaCl2 2. 
pH 7.4. 120μm transverse free floating sections of L3-L5 spinal cord segment were 
obtained using Vibratome (Leica VT1000S) and left in HEPES buffer solution to 
recover for 30 minutes. Slice were then incubated in an imaging chamber and held in 
place with a U-shaped stainless steel rod. Imaging was carried out excluding the 
areas damaged by tissue sectioning 30 μm above and beneath the section. 
Hippocampal slices were prepared from P30–P40 mice. Animals were decapitated 
after being anesthetized with halothane, and whole brains were rapidly immersed for 
10 min in ice-cold continuously oxygenated (95% O2, 5% CO2; pH 7.4) artificial 
cerebrospinal fluid (ACSF) containing 125 mM NaCl, 2.5 mM KCl, 1 mM MgCl2, 2 
mM CaCl2, 1.125 mM NaH2PO4, 10 mM glucose and 26 mM NaHCO3. Transverse 
250-μm hippocampal slices were cut at 4 °C with a vibratome (DSK, Kyoto, Japan) in 
oxygenated ACSF and allowed to recover for 1 h in oxygenated 10% diluted ACSF 
(Hypo-ACSF, 270 mOsm). Individual slices were transferred to the recording 
chamber under the microscope and superfused with oxygenated Hypo-ACSF at the 
rate of 1.5 ml per min at room temperature (23–25 °C). 
 
  
Confocal time-lapse microscopy 
Time-lapse video microscopy was carried out on a spinning disk confocal 
ultraviewVox (Cellular imaging, Perkin Elmer) and diode solid lasers (wavelengths: 
405, 488, 568 and 647nm) were used as excitation sources. Imaging was performed 
using a Hamamatsu EMCCD camera (Hamamatsu, Japan). The z-position was 
controlled by a nano-scan piezo-drive stage (Prior) via the Perkin-Elmer pilot 
software (VolocityImprovision, UK). Time-lapses were carried out at 37° C and 
5%CO2, unless is specified on the text.  
For phagocytosis assays microglia cells expressing Cl-Sensor probe (Batti et al., 
2013) were co-incubated with fluorescent heat killed S. cerevisiae yeast (2.5 x106 
cells per dish). Images were taken on a Perkin Elmer spinning disk microscope every 
minute for 30 minutes.  
For spinal cord ex vivo time lapse Z optical series covered 40 μm of thickness 
throughout the tissue with 0.5 μm thickness. Images were taken of the dorsal horn of 
the ipsilateral side of the spinal cord every minute for 30 minutes. 
 
Wide-field time lapse imaging of microglial processes 
Wide-field time-lapse fluorescence images in hippocampal slices were acquired at 
room temperature (24 - 25 °C) using a customized digital imaging microscope. 
Excitation of GFP was achieved using a 1-nm-bandwidth polychromatic light selector 
(Till Polychrome V), equipped with a 150 W xenon lamp (Till Photonics, Germany). 
Fluorescence was visualized using an upright microscope (Axioscope) equipped with 
a 40x water-immersion objective (AchroplanCarlZeiss, USA) and a digital 12 bit CCD 
camera system (SensiCam, PCO AG, Germany). All the peripheral hardware control, 
image acquisition and image processing were achieved using customized software 
Till Vision v. 4.0 (Till Photonics, Germany). A glass pipette containing adenosine 5’-
triphosphate magnesium salt (ATP, 2 mM; Sigma Aldrich) was placed in the stratum 
radiatum in the center of the recording field. Mg-ATP was pressure applied to the 
  
slices (100 ms; 5 psi) with a Picospritzer III (Parker Instrumentation). Changes in 
GFP fluorescence distribution was monitored by acquiring a fluorescent stack every 
10 seconds for 50 minutes. To quantify the speed of microglial process 
rearrangement toward the pipette tip, the increase of GFP fluorescence was 
measured in a circular area centered on the pipette tip (10 µm radius). At each time 
point the fluorescence increase in the area was calculated as ∆F = F-F0, and then 
divided for F0 (∆F/F0, where F0 is the average fluorescence before ATP puff) to 
normalize the difference in basal GFP fluorescence. Slices were used from 2 to 7 
hours after cutting. For these experiments CX3CR1GFP:: LysMCre::TMEM16Ffl/- and 
CX3CR1GFP::LysMCre::TMEM16Ffl/fl were used as cKOGFP and 
CX3CR1GFP::TMEM16FFl/+ and CX3CR1GFP::TMEM16FFl/fl (in the absence of Cre) 
mice were used as ControlGFP. 
 
Tracking analysis of single microglial process 
All images were processed using ImageJ software. Images stacks were exported as 
.avi files to enable manual cell processes tracking on the ImageJ “Manual Tracking” 
plug-in (http://imagej.nih.gov/ij/plugins/track/track.html). To obtain quantitative 
analysis of tracks parameters, data were analyzed with ImageJ and Origin 7 
(OriginLab Co.) software. Stacks were first background subtracted to optimize 
contrast. To obtain x-y coordinates of single processes, track positions were 
transferred into a new coordinate system, in which the ATP-containing pipette tip was 
set as origin (x = 0, y = 0). For each moving process (i), with position vector Ri(t), the 
change in position from one frame to the next (ΔRi(t)), and the instantaneous velocity 
(vi(t)) were given by ΔRi(t) = Ri(t+Δt)− Ri(t), and vi(t) = ΔRi(t)/Δt respectively, where 
Δt is the elapsed time among the two frames. The mean elongation velocity of each 
process was calculated as <v>=dx/dt, expressed in μm/min, defining dx as the mean 
accumulated distance of each process i sampled within the time interval dt. 
 
  
In Situ Hybridization 
Cells grown on coverslips were fixed in 4% PFA for 30 min, washed in PBS and 
permeabilized by overnight incubation in 70% ethanol at 4C. In situ hybridization was 
carried out using an in vitro transcribed probe generated from the full coding region 
of TMEM 6F.  Cells were acetylated and hybridized with the probe in 50% 
formamide, 5X SSC, 5x Denhardt’s solution, 500 ug/ml salmon sperm DNA, and 250 
ug/ml tRNA overnight at 56 C. After post-hybridization washes with 50% formamide, 
2X SSC at 52.5 C, and with 2X SSC at ambient temperature, sections were blocked 
and incubated overnight with anti-digoxigenin-AP  (Roche; at 1:1000). Signal 
detection was done using NBT/BCIP substrate.  
 
RNA fluorescence in situ hybridization and immunofluorescence 
Spinal cords were collected, fresh frozen in OCT and sectioned at 20 µm onto 
Superfrost Plus slides. In situ hybridization was performed using a Fluorescein-
labeled probe generated from a full-length TMEM16F cDNA. Briefly, sections were 
fixed in 4% paraformaldehyde, digested with proteinase K for 5 min, acetylated, and 
hybridized with the probes in 50% formamide, 5X SSC, 5x Denhardt’s solution, 500 
ug/ml salmon sperm DNA, and 250 ug/ml tRNA overnight at 56º C. After post-
hybridization washes with 50% formamide, 2X SSC  at 45 C, and with 2X SSC at 
ambient temperature, sections were blocked and incubated overnight with mouse 
anti-fluorescein (Roche; at 1:100) and was detected by a donkey anti-mouse Alexa 
555. The sections were then incubated with rabbit anti-Iba1 (Wako; at 1:200), 
followed by donkey anti-rabbit Alexa 488. 
 
Real Time PCR 
Homogenates of DRGs, Brain, Kidney, L4–L6 segment of the lumbar spinal cord and 
lysates of microglia cells were subjected to total RNA extraction with an RNeasy 
Micro Kit (Qiagen) according to the manufacturer’s instruction. mRNA was reverse 
  
transcribed to cDNA by Superscript II reverse transcription (Life Technology), using 
Oligo(dT) primers. Quantitative PCR was performed on a LightCycler 480 PCR 
instrument (Roche) using SYBR green I master (Roche). The primers were as 
follows: TMEM16A primers (forward: 5’-GAGGCCAGTAGCCATCAGAG-3’), 
(reverse:  5’-TCTGGAAGTCGCTGACATTG-3’), TMEM16B (forward: 5’-
CGGATATCCCCACTGACATC-3’), (reverse: 5’-ACCCTGAGGATGCTATGCTG-3’) 
TMEM16C (forward: 5’-CGAAAGCCAAGTAAGCCAAG-3’), (reverse: 5’-
AAGACTGTGGCCCATATTGC-3’), TMEM16D (forward: 5’-
CGACTTCATCCCTCGCTTAG-3’), (reverse: 5’-TAGGGTGCCAAAGAGTGAGG-3’), 
TMEM16E (forward: 5’-CCAGGAGTATGAGAGCAGCC-3’), (reverse: 5’-
AATGATGGTTAGCTGGGTGG-3’), TMEM16F (forward: 5’-
GCACTTGGAGCAAAGAGGTC-3’), (reverse: 5’-TGCTGTAGCTCAACGGTGTC-3’), 
TMEM16G (forward: 5’-AAGGTACTTCGGGGAGAAGG-3’), (reverse: 5’-
AAGAACAGTCGGAGCACAGC-3’), TMEM16H (forward: 5’-
CAAGGTTATGCTAGCCCTGC-3’), (reverse: 5’-TCTTTTAGGCGGTCCATGTC-3’), 
TMEM16I (forward: 5’-ACCTTGTGGAAATCCGTCTG-3’), (reverse: 5’-
ACGGGCCATAGTGGTACTTG-3’), TMEM16J (forward: 5’-
ACCTTGTGGAAATCCGTCTG-3’), (reverse: 5’-ACGGGCCATAGTGGTACTTG-3’) 
for RT-PCR of TMEM16 family members. All primers were purchased from Sigma 
Aldrich, Italy. Each mRNA expression level was normalized to ubiquitin or GADPH. 
 
Western blotting 
Harvested tissues were homogenized on ice in buffer containing 10 mM Hepes, 1mM 
EDTA, 250 mM sucrose and proteinase inhibitor using a Politron homogenizer. 
Homogenates were centrifuged at 1500 rpm for 5 min at 4 ºC. For the membrane 
fraction, 100 mM NaCO3 (pH 11.2) was then added to the supernatant and shaken 
for 45 min at 4 ºC. Lysates were incubated in sample buffer for 30 min at 37 ºC. 
Lysates from HEK293 cells expressing TMEM16F were used as positive control. 10 
  
μg lysates were loaded for gel electrophoresis. Proteins were transferred to a 
nitrocellulose membrane, and incubated with rabbit anti-TMEM16F (HPA038958, 
Sigma) antibody in 0.1% Tween TBS + 5% dry nonfat milk, and HRP-linked donkey 
anti-rabbit IgG (NA934V, GE Healthcare) secondary antibody. Detection was 
performed using the ECL Western blot chemiluminescent reagent (RPN2106, GE 
Healthcare). 
Immunohistochemistry 
Mice were anesthetized with 2.5% Avertin and subjected to intracardiac perfusion 
with fresh 4% paraformaldehyde in PBS. Spinal cord and sciatic nerve were 
dissected and postfixed with 4% paraformaldehyde in PBS for 120 and 30 minutes, 
respectively. L3-L5 Lumbar segments of the spinal cord were embedded in 2% low 
melting agarose in water and 50μm transverse free-floating section were obtained 
using a Vibratome (Leica). Free floating section were permeabilized in 0.5% Triton-X 
in PBS for 1 hour at room temperature. Unspecific binding was blocked using a 1 
hour incubation with 1% BSA in 0.5% Triton X-100. Nerves were cryoprotected in 
30% sucrose PBS, and cut on a cryostat (18 μm; Leica).  Cryosections were 
permeabilized using 0.2% Triton X-100 in TBS for 10 minutes and blocked with 5% 
normal goat serum in 0.1% Tween-20 TBS for 30 minutes at room temperature. The 
following primary antibodies were incubated overnight at 4°C at the described 
dilution: rabbit anti-Iba1 (019-19741, Wako; 2.5 μg/ml), rat anti-CD68 (Abd Biotech; 
10 μg/ml), mouse anti-NeuN (1:250), rabbit anti-P2X4 receptor (ab82329, Abcam; 
1:200), rabbit anti-RFP (600-401-379, Rockland; 5 μg/ml), rabbit anti-GABA (A2052, 
Sigma;1:2000). For co-staining with RFP or P2X4R, a mouse goat anti-Iba1 (Novus; 
5 μg/ml) was used. Anti-rabbit-, anti-rat and anti-mouse Alexa-488, -546 or -647 
secondary antibodies (2 μg/ml) (Life Technologies) were applied and incubated for 
90 minutes at room temperature.  Dapi (5 μg/ml) was applied for 20 minutes and 
washed by PBS. Sections were mounted on slides using Pro-long Gold (Life 
Technologies). Confocal microscopy was performed using a TCS-SP5 (Leica) Laser 
  
Scanning System. For free floating slice imaging, Z optical series covered 42 μm of 
thickness throughout the tissue with 0.5 μm thickness. For imaging of cryosections Z 
optical series covered 12 μm of thickness throughout the tissue with 0.5 μm 
thickness. Low magnification spinal cord tiled images were acquired using wide-field 
microscope (Leica Microsystems).  
 
Confocal Image analysis 
Three-dimensional reconstructions of confocal stacks and surface rendering were 
generated using Imarisbitplane Software (Bitplane, Zurich, Switzerland). Surface, 
Filament and SpotsImaris modules were used for segmentation and tracking of 
microglial cells, microglia processes and neuron terminals, respectively.  For 
microglia branch motility analysis, the volume of rectangular cuboid containing single 
objects was measured for each timepoint, using IMARIS Surface module. For 
detection of internalized neuronal terminals by microglia, objects identified by the 
spots module were filtered by mean intensity with a thresholded green (microglia) 
intensity. Volocity 3D image analysis software (Perkin Elmer) was used for three-
dimensional reconstructions and quantitative analysis of confocal stack of nerve 
sections. 
 
Cytokine arrays 
Mice at day 4 after PNL induction were trascardially perfused with PBS, and sciatic 
nerve fragments were excised and immediately frozen in liquid nitrogen. Samples 
were thawed, homogenized and protein extracted. Contralateral and ipsilateral sciatic 
nerve protein extracts were pooled together from 4 mice to produce 130 µg protein. 
Each sample was incubated with a separate pre-spotted membrane of 40 
cytokines/chemokines and processed according to manufacturer’s instructions (R&D 
Systems, mouse cytokine array panel A, no. ARY006). The signal was revealed with 
streptavidin-HRP-conjugated secondary antibody and chemiluminescence. Intensity 
  
of selected dots was analyzed in ImageJ, and mean pixel density for each protein 
was calculated by subtracting background and averaging the duplicates. 
 
Statistical Analysis 
Data analysis was performed with PRISM (GraphPad), Origin 6.1 (OriginLab Co.) 
and SigmaPlot (SyStat). All data are reported as mean ± s.e.m. Statistical 
significance was determined by one-way ANOVA test followed by Bonferroni post 
hoc test in case of significance, two-way ANOVA, Student’s t-test, χ2 test, 
Kolmogorov-Smirnov or Mann Whitney test. 
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